{ "schemaVersion": "gships-review-packet-1", "packetId": "opportunities:opp-trish", "stableId": "opp-trish", "family": "opportunities", "slug": "opp-trish", "title": "TRISH funding and Catalyst pathway", "status": "prepared-human-review-not-started", "release": { "releaseId": "public-alpha-2026-07-26-research-visuals-r14", "sourceCommit": "3eb036fce3d711336c8c605625895e8a2e799ab0", "corpusGeneratedAt": "2026-07-25", "frozenAt": "2026-07-26T22:50:50.000Z", "canonicalOrigin": "https://gships.dammonburden.com" }, "paths": { "human": "/review/opportunities/opp-trish", "family": "/review/opportunities", "packet": "/review-packets/opportunities/opp-trish.a2ef26c9bedac14f.json", "decisionTemplate": "/review-packets/opportunities/opp-trish.a2ef26c9bedac14f.decision-template.json", "worksheet": "/review-packets/opportunities/opp-trish.a2ef26c9bedac14f.worksheet.md", "byFingerprint": "/review-packets/by-fingerprint/a2ef26c9bedac14f6bfa568b843e20045bccc976356fad94509eb0daf9fb2986.json" }, "boundary": "Prepared review packet; human review has not started. This packet is not a completed review, endorsement, reviewer appointment, partnership, or authorization to act.", "governingPolicies": [ { "id": "policy-editorial-governance-001", "version": "0.1.0", "path": "/editorial-policy", "recordType": "governing-policy", "fingerprint": "1f6a1f823e8bfe891b6a707c5dce2ee2337c0bb7d915b48d6060ca82b8da1b47", "snapshot": { "id": "policy-editorial-governance-001", "version": "0.1.0", "status": "foundation-policy-controls-not-yet-staffed", "adoptedForFoundation": "2026-07-25", "title": "Editorial governance and independent review", "publisher": "GShips Project", "maintainer": "Dammon Burden", "publisherInterest": "The maintainer intends to explore a commercial venture based on some GShips work. No entity, outside funding, customer, sponsor, or indexed-organization relationship currently exists.", "currentBoundary": "No independent domain reviewer or review council is currently appointed. Foundation records and outlines may not be represented as independently reviewed.", "reviewerSelection": [ "Publish the reviewer’s name, relevant credentials or lived expertise, review scope, compensation status, and declared conflicts with consent.", "Select for the actual claim domain rather than general prestige; include affected-community and disability-led expertise where rights or access are involved.", "Do not treat an employee, investor, customer, sponsor, source author, or directly supervised collaborator as independent for the affected claim." ], "reviewProcess": [ "Provide the exact claim, sources, locators, assumptions, counterevidence, transfer limits, and proposed evidence dimensions.", "Record approve, revise, contest, or reject at claim level; silence and event attendance never count as review.", "Publish material minority findings and the editor’s reasoned response.", "High-consequence medical, reproductive, nuclear, radiation, cybersecurity, governance, and dual-use claims require two qualified independent reviewers with complementary scopes.", "A reviewer may recuse at any time; unresolved conflicts or missing expertise block the reviewed label." ], "appealAndCorrection": [ "A correction receives a reference identifier and triage record; safety-critical allegations receive priority.", "A material editorial decision may be appealed to a reviewer not involved in the original decision once such a panel exists.", "Substantive reversals, unresolved disputes, and removed conclusions receive a dated public record that protects reporter privacy.", "No sponsor, customer, founder, or reviewer may purchase, suppress, or unilaterally assign an evidence grade." ], "publicationGate": "Public 1.0 requires named review coverage across every Academy track, documented high-consequence two-person review, a material-corrections log, reviewer conflict records, and an operating appeal path.", "correctionPath": "/corrections" } }, { "id": "policy-dual-use-001", "version": "0.1.0", "path": "/dual-use", "recordType": "governing-policy", "fingerprint": "81637e2849f9c0866d23f7174eb9a2ce522b86313167ebf5022fca122d6e506c", "snapshot": { "id": "policy-dual-use-001", "version": "0.1.0", "status": "planned-controls-not-yet-operational", "adoptedForFoundation": "2026-07-25", "title": "Civil, defensive, and rights-preserving use boundary", "summary": "GShips may research safety, resilience, logistics, communications, recovery, and cyber defense only within explicit end-use, rights, and independent-review controls. Calling an activity defensive is never sufficient by itself.", "scopeTrigger": "Apply dual-use review before accepting or materially advancing customer, funder, collaborator, operational, procurement, or publication-sensitive work whose capability, data, end use, or transfer could reasonably enable a prohibited use. Public non-actionable education still follows prohibited-content and sensitive-publication controls.", "allowedInPrinciple": [ "Safety engineering and independently assessed protection", "Resilience, graceful degradation, recovery, and disaster response", "Civil logistics, maintenance, communications, and knowledge continuity", "Cyber defense, secure software, incident response, and recovery", "Rights-preserving health, accessibility, ecology, education, and governance research" ], "prohibited": [ "Identification, tracking, prioritization, or engagement of people or assets for force, weapons, repression, or offensive operations; safety navigation, astronomy, collision avoidance, search and rescue, and independently governed planetary defense are not prohibited by this clause", "Weapons command-and-control or targeting support", "Offensive access, persistence, exploitation, or destructive cyber payloads", "Mass surveillance, biometric repression, or political-control systems", "Autonomous force application", "Coercive reproductive, medical, genetic, disability, or civic control", "Nonconsensual experimentation or treating residents as research instruments" ], "reviewRequiredBeforeAnyRelevantWork": [ "Customer, funder, collaborator, jurisdiction, beneficial-owner, and end-use screening", "Export-control and sanctions review by qualified counsel when applicable", "Written scope, allowed-use, prohibited-use, audit, termination, and incident clauses", "Independent stop-work authority with a named alternate and founder recusal", "Sensitive-publication and information-hazard review", "Whistleblowing, escalation, incident response, appeal, and anti-retaliation paths", "Aggregate transparency reporting that protects legitimate privacy and security" ], "currentBoundary": "No screening body, independent stop-work authority, contractual controls, or appeal body currently exists. Therefore no relevant customer, defense, dual-use, or operational engagement is authorized by this policy.", "changeControl": "Material changes require a dated public rationale, independent review, and may not be approved by the founder alone.", "correctionPath": "/corrections" } } ], "reviewContract": { "questions": [ { "id": "question-1", "text": "Does the official source support the opportunity identity, status, timing, eligibility, and access constraints?", "required": true }, { "id": "question-2", "text": "Is the proposed fit specific and proportionate without implying availability, invitation, selection, or funding?", "required": true }, { "id": "question-3", "text": "What deadline, rule, jurisdiction, cost, conflict, or accessibility fact would change the proposed next action?", "required": true } ], "exclusions": [ "Review does not submit, register, apply, contact, commit, purchase, or establish eligibility.", "Provider prestige and apparent fit cannot replace current official terms." ], "requestedScopeCodes": [ "ecosystem-due-diligence", "opportunity-eligibility-access" ], "dispositions": [ "approve", "revise", "contest", "reject", "recuse" ], "prohibitedInputs": [ "private legal names or contact details", "identity documents or raw credential files", "accessibility or medical records", "confidential conflict evidence", "classified, export-controlled, proprietary, or exploit material" ], "freshness": { "maximumDecisionAgeFromFreezeDays": 30, "eventOccurrenceRule": "Not applicable to this packet family." }, "completionRule": "Every primary record must receive the required number of valid, current-fingerprint approvals; every complementary scope group and required domain must be covered; any unresolved revise, contest, or reject disposition blocks publication.", "highConsequenceRule": "Named medical, reproductive, nuclear, radiation, cybersecurity, governance, and dual-use conclusions require two distinct qualified independent humans covering complementary domain-method and rights/public-interest scopes." }, "primaryRecords": [ { "recordType": "opportunity", "recordId": "opp-trish", "title": "TRISH funding and Catalyst pathway", "publicPath": "/opportunities/opp-trish", "recordFingerprint": "9a66035ab0351f9eef07d11f2a9239e3868a644cbae4ed566c83434b3dd5c520", "reviewRequirements": { "minimumIndependentApprovals": 1, "highConsequenceDomains": [], "requiredDomainCodes": [], "requiredComplementaryScopeGroups": [ { "id": "bounded-competence", "scopeClass": "bounded-competence", "oneOf": [ "ecosystem-due-diligence", "opportunity-eligibility-access" ] } ], "unresolvedNegativeFindingBlocksPublication": true, "currentUntil": "2026-08-01" }, "referenceIds": [], "snapshot": { "id": "opp-trish", "name": "TRISH funding and Catalyst pathway", "url": "https://www.bcm.edu/academic-centers/space-medicine/translational-research-institute/funding", "provider": "TRISH", "kind": "Health research funding", "timing": "Active. A ground-based venous-thromboembolism solicitation is due August 18, 2026 at 11:59 p.m. Eastern Time; the Catalyst Grants Program also publishes current priority topics outside regular cycles.", "fit": "Autonomous medicine and commercial-space health", "status": "active", "verifiedAt": "2026-07-25", "currentUntil": "2026-08-01", "eligibility": "The VTE call is open to U.S.-based institutions, commercial entities, and other research organizations. TRISH states that federally funded projects are led by investigators at U.S.-based institutions; the Catalyst solicitation and each call control detailed eligibility.", "accessNotes": "The VTE call may award up to $500,000, with selections anticipated in December 2026 and a February 2027 start. TRISH warns that awards remain subject to NASA funding availability and may be delayed, reduced, or canceled.", "founderAction": "Only consider a call when qualified medical investigators, institutional oversight, a precise Human Research Roadmap gap, and a validated study plan exist; seek separate authorization before any proposal.", "evidenceBoundary": "Official Baylor/TRISH funding page reviewed. It states current programs, deadline, broad eligibility, award ceiling, and funding contingency. No scientific fit, investigator eligibility, ethics approval, or award is implied.", "relationship": "indexed only; no formal relationship", "actionStatus": "proposed; not undertaken", "conflicts": "Human health and medical-system work is high consequence; clinical validity, research ethics, privacy, conflicts of interest, and funding dependence require independent specialist review.", "whatWouldChange": "New Catalyst topics, amended VTE instructions, confirmed qualified investigators and institutional approvals, or a budget change would alter fit." } } ], "linkedRecords": [ { "recordType": "opportunity-task-match", "recordId": "opportunity-match-radiation-trish", "title": "radiation-life-course-health · opp-trish", "publicPath": "/partners", "recordFingerprint": "4723d055cf47501e6af891fc154644c4da657ce3c113ee63aebd3ed400924d3e" } ], "referenceSnapshots": [ { "sourceId": "official-opportunity-opp-trish", "sourceRecordType": "reference-source", "sourceFingerprint": "c348ff005fbd23c370f8d66cdb3332df4c8ca7de3f48c470006e1223effcb6d2", "snapshot": { "title": "TRISH funding and Catalyst pathway", "url": "https://www.bcm.edu/academic-centers/space-medicine/translational-research-institute/funding", "checkedAt": "2026-07-25", "scopeNote": "Official Baylor/TRISH funding page reviewed. It states current programs, deadline, broad eligibility, award ceiling, and funding contingency. No scientific fit, investigator eligibility, ethics approval, or award is implied.", "subjectRecordType": "opportunity", "subjectRecordId": "opp-trish" } } ], "packetFingerprint": "a2ef26c9bedac14f6bfa568b843e20045bccc976356fad94509eb0daf9fb2986" }